BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19093898)

  • 1. Inorganic nanoparticles for predictive oncology of breast cancer.
    Yezhelyev M; Yacoub R; O'Regan R
    Nanomedicine (Lond); 2009 Jan; 4(1):83-103. PubMed ID: 19093898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalization of inorganic nanoparticles for bioimaging applications.
    Erathodiyil N; Ying JY
    Acc Chem Res; 2011 Oct; 44(10):925-35. PubMed ID: 21648430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inorganic nanoparticles for cancer imaging and therapy.
    Huang HC; Barua S; Sharma G; Dey SK; Rege K
    J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inorganic nanomedicine--part 1.
    Sekhon BS; Kamboj SR
    Nanomedicine; 2010 Aug; 6(4):516-22. PubMed ID: 20417313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface engineering of inorganic nanoparticles for imaging and therapy.
    Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
    Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
    Shi J; Xiao Z; Kamaly N; Farokhzad OC
    Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inorganic nanoparticles in diagnosis and treatment of breast cancer.
    Núñez C; Estévez SV; Del Pilar Chantada M
    J Biol Inorg Chem; 2018 May; 23(3):331-345. PubMed ID: 29453558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of functional quantum dots in cancer diagnosis and therapy: a review].
    Han S; Xia T; Li Q; Guo J; Lu P
    Sheng Wu Gong Cheng Xue Bao; 2013 Jan; 29(1):10-20. PubMed ID: 23631114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle therapeutics for prostate cancer treatment.
    Sanna V; Sechi M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S31-6. PubMed ID: 22640911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery.
    Montenegro JM; Grazu V; Sukhanova A; Agarwal S; de la Fuente JM; Nabiev I; Greiner A; Parak WJ
    Adv Drug Deliv Rev; 2013 May; 65(5):677-88. PubMed ID: 23280372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimer-nanoparticle conjugates in nanomedicine.
    Parat A; Bordeianu C; Dib H; Garofalo A; Walter A; Bégin-Colin S; Felder-Flesch D
    Nanomedicine (Lond); 2015; 10(6):977-92. PubMed ID: 25867861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of inorganic nanomaterials in biomedical imaging.
    Li J; Chang X; Chen X; Gu Z; Zhao F; Chai Z; Zhao Y
    Biotechnol Adv; 2014; 32(4):727-43. PubMed ID: 24389087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising approaches in using magnetic nanoparticles in oncology.
    Mikhaylov G; Vasiljeva O
    Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine and veterinary science: the reality and the practicality.
    Underwood C; van Eps AW
    Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel.
    Petrelli F; Borgonovo K; Barni S
    Expert Opin Pharmacother; 2010 Jun; 11(8):1413-32. PubMed ID: 20446855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.